2012 Lung Cancer Research Foundation Annual Grant Program
Joseph Bertino, MD
Cancer Institute of New Jersey/Robert Wood Johnson Medical School
Research Project:
A novel anti tumor peptide that targets E2F in small cell lung cancer
Summary:
The study will focus on a unique new drug for the treatment of small cell lung cancer that targets a critical pathway for the disease. Targeting the E2F mechanism has been unsuccessful in other studies, but this proposal considers a unique mechanism of action.